{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:37:32Z","timestamp":1779878252584,"version":"3.53.1"},"publisher-location":"Singapore","reference-count":64,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819901128","type":"print"},{"value":"9789819901135","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_17","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"313-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pseudotyped Virus for Flaviviridae"],"prefix":"10.1007","author":[{"given":"Leiliang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annan","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105266","volume":"199","author":"K Yato","year":"2022","unstructured":"Yato, K., et al.: Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccine. Antivir. Res. 199, 105266 (2022). https:\/\/doi.org\/10.1016\/j.antiviral.2022.105266","journal-title":"Antivir. Res."},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens11030337","volume":"11","author":"J Agnetti","year":"2022","unstructured":"Agnetti, J., Desterke, C., Gassama-Diagne, A.: Impact of HCV infection on hepatocyte polarity and plasticity. Pathogens (Basel, Switzerland). 11, 1 (2022). https:\/\/doi.org\/10.3390\/pathogens11030337","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"17_CR3","doi-asserted-by":"publisher","unstructured":"Dearborn, A.D., Marcotrigiano, J.: Hepatitis C virus structure: defined by what it is not. Cold Spring Harb. Perspect. Med. 10 (2020). https:\/\/doi.org\/10.1101\/cshperspect.a036822","DOI":"10.1101\/cshperspect.a036822"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jhep.2019.01.033","volume":"70","author":"DH Banda","year":"2019","unstructured":"Banda, D.H., et al.: A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors. J. Hepatol. 70, 1082\u20131092 (2019). https:\/\/doi.org\/10.1016\/j.jhep.2019.01.033","journal-title":"J. Hepatol."},{"key":"17_CR5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016010","volume":"296","author":"F Zheng","year":"2021","unstructured":"Zheng, F., Li, N., Xu, Y., Zhou, Y., Li, Y.P.: Adaptive mutations promote hepatitis C virus assembly by accelerating core translocation to the endoplasmic reticulum. J. Biol. Chem. 296, 100018 (2021). https:\/\/doi.org\/10.1074\/jbc.RA120.016010","journal-title":"J. Biol. Chem."},{"key":"17_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129997","volume":"1865","author":"E Gruszewska","year":"2021","unstructured":"Gruszewska, E., Grytczuk, A., Chrostek, L.: Glycosylation in viral hepatitis. Biochim. Biophys. Acta, Gen. Subj. 1865, 129997 (2021). https:\/\/doi.org\/10.1016\/j.bbagen.2021.129997","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"17_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101626","volume":"45","author":"S Roger","year":"2021","unstructured":"Roger, S., Ducancelle, A., Le Guillou-Guillemette, H., Gaudy, C., Lunel, F.: HCV virology and diagnosis. Clin. Res. Hepatol. Gastroenterol. 45, 101626 (2021). https:\/\/doi.org\/10.1016\/j.clinre.2021.101626","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3748\/wjg.v27.i13.1267","volume":"27","author":"R Chaudhari","year":"2021","unstructured":"Chaudhari, R., Fouda, S., Sainu, A., Pappachan, J.M.: Metabolic complications of hepatitis C virus infection. World J. Gastroenterol. 27, 1267\u20131282 (2021). https:\/\/doi.org\/10.3748\/wjg.v27.i13.1267","journal-title":"World J. Gastroenterol."},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ajpath.2019.01.018","volume":"189","author":"MC Navas","year":"2019","unstructured":"Navas, M.C., et al.: Hepatitis C virus infection and cholangiocarcinoma: an insight into epidemiologic evidences and hypothetical mechanisms of oncogenesis. Am. J. Pathol. 189, 1122\u20131132 (2019). https:\/\/doi.org\/10.1016\/j.ajpath.2019.01.018","journal-title":"Am. J. Pathol."},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"TJ Chambers","year":"1990","unstructured":"Chambers, T.J., Hahn, C.S., Galler, R., Rice, C.M.: Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44, 649\u2013688 (1990)","journal-title":"Annu. Rev. Microbiol."},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","volume":"178","author":"J-HJ Chu","year":"2007","unstructured":"Chu, J.-H.J., Chiang, C.-C.S., Ng, M.-L.: Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection. J. Immunol. 178, 2699\u20132705 (2007)","journal-title":"J. Immunol."},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1749-6632.2001.tb02681.x","volume":"951","author":"DJ Gubler","year":"2001","unstructured":"Gubler, D.J.: Human arbovirus infections worldwide. Ann. N. Y. Acad. Sci. 951, 13\u201324 (2001). https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb02681.x","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"17_CR13","doi-asserted-by":"publisher","unstructured":"Li, Q., Liu, Q., Huang, W., Li, X., Wang, Y.: Current status on the development of pseudoviruses for enveloped viruses. Rev. Med. Virol. 28 (2018). https:\/\/doi.org\/10.1002\/rmv.1963","DOI":"10.1002\/rmv.1963"},{"key":"17_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.126993","volume":"258","author":"Q Xiang","year":"2022","unstructured":"Xiang, Q., Li, L., Wu, J., Tian, M., Fu, Y.: Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies. Microbiol. Res. 258, 126993 (2022). https:\/\/doi.org\/10.1016\/j.micres.2022.126993","journal-title":"Microbiol. Res."},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","volume":"197","author":"B Bartosch","year":"2003","unstructured":"Bartosch, B., Dubuisson, J., Cosset, F.L.: Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197, 633\u2013642 (2003). https:\/\/doi.org\/10.1084\/jem.20021756","journal-title":"J. Exp. Med."},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4939-8976-8_2","volume":"1911","author":"L Riva","year":"2019","unstructured":"Riva, L., Dubuisson, J.: Similarities and differences between HCV Pseudoparticle (HCVpp) and cell culture HCV (HCVcc) in the study of HCV. Methods in molecular biology (Clifton, N.J.). 1911, 33\u201345 (2019). https:\/\/doi.org\/10.1007\/978-1-4939-8976-8_2","journal-title":"Methods in molecular biology (Clifton, N.J.)"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"16931","DOI":"10.1074\/jbc.RA120.014761","volume":"295","author":"M Palor","year":"2020","unstructured":"Palor, M., et al.: Cholesterol sensing by CD81 is important for hepatitis C virus entry. J. Biol. Chem. 295, 16931\u201316948 (2020). https:\/\/doi.org\/10.1074\/jbc.RA120.014761","journal-title":"J. Biol. Chem."},{"key":"17_CR18","doi-asserted-by":"publisher","unstructured":"Kalemera, M.D., et al.: Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins. J. Gen. Virol. 102 (2021). https:\/\/doi.org\/10.1099\/jgv.0.001512","DOI":"10.1099\/jgv.0.001512"},{"key":"17_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2019.113714","volume":"274","author":"HR Soares","year":"2019","unstructured":"Soares, H.R., et al.: Enhancing hepatitis C virus pseudoparticles infectivity through p7NS2 cellular expression. J. Virol. Methods. 274, 113714 (2019). https:\/\/doi.org\/10.1016\/j.jviromet.2019.113714","journal-title":"J. Virol. Methods"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1743-422X-6-115","volume":"6","author":"HJ Lee","year":"2009","unstructured":"Lee, H.J., et al.: The prM-independent packaging of pseudotyped Japanese encephalitis virus. Virol. J. 6, 115 (2009). https:\/\/doi.org\/10.1186\/1743-422X-6-115","journal-title":"Virol. J."},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1128\/JVI.02499-09","volume":"84","author":"H Tani","year":"2010","unstructured":"Tani, H., et al.: Involvement of ceramide in the propagation of Japanese encephalitis virus. J. Virol. 84, 2798\u20132807 (2010). https:\/\/doi.org\/10.1128\/JVI.02499-09","journal-title":"J. Virol."},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virusres.2016.12.007","volume":"229","author":"H Liu","year":"2017","unstructured":"Liu, H., et al.: Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins. Virus Res. 229, 9\u201316 (2017). https:\/\/doi.org\/10.1016\/j.virusres.2016.12.007","journal-title":"Virus Res."},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.virol.2011.01.011","volume":"412","author":"H Kambara","year":"2011","unstructured":"Kambara, H., et al.: Involvement of cyclophilin B in the replication of Japanese encephalitis virus. Virology. 412, 211\u2013219 (2011). https:\/\/doi.org\/10.1016\/j.virol.2011.01.011","journal-title":"Virology"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1128\/JVI.00903-12","volume":"86","author":"Y-Z Zhu","year":"2012","unstructured":"Zhu, Y.-Z., et al.: Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J. Virol. 86, 13407\u201313422 (2012). https:\/\/doi.org\/10.1128\/JVI.00903-12","journal-title":"J. Virol."},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12275-014-3529-y","volume":"52","author":"HJ Lee","year":"2014","unstructured":"Lee, H.J., et al.: Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test. J. Microbiol. 52, 435\u2013440 (2014). https:\/\/doi.org\/10.1007\/s12275-014-3529-y","journal-title":"J. Microbiol."},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"45375","DOI":"10.1038\/srep45375","volume":"7","author":"Q Xu","year":"2017","unstructured":"Xu, Q., et al.: E3 ubiquitin ligase Nedd4 promotes Japanese encephalitis virus replication by suppressing autophagy in human neuroblastoma cells. Sci. Rep. 7, 45375 (2017). https:\/\/doi.org\/10.1038\/srep45375","journal-title":"Sci. Rep."},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijid.2020.08.037","volume":"100","author":"HJ Lee","year":"2020","unstructured":"Lee, H.J., et al.: Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea. Int. J. Infect. Dis. 100, 53\u201358 (2020). https:\/\/doi.org\/10.1016\/j.ijid.2020.08.037","journal-title":"Int. J. Infect. Dis."},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.virol.2007.06.026","volume":"368","author":"HP Hu","year":"2007","unstructured":"Hu, H.P., Hsieh, S.C., King, C.C., Wang, W.K.: Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses. Virology. 368, 376\u2013387 (2007). https:\/\/doi.org\/10.1016\/j.virol.2007.06.026","journal-title":"Virology"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1099\/jgv.0.001346","volume":"100","author":"J Rana","year":"2019","unstructured":"Rana, J., Slon Campos, J.L., Poggianella, M., Burrone, O.R.: Dengue virus capsid anchor modulates the efficiency of polyprotein processing and assembly of viral particles. J. Gen. Virol. 100, 1663\u20131673 (2019). https:\/\/doi.org\/10.1099\/jgv.0.001346","journal-title":"J. Gen. Virol."},{"key":"17_CR30","doi-asserted-by":"publisher","unstructured":"Pan, T., et al.: Nonsteroidal anti-inflammatory drugs potently inhibit the replication of zika viruses by inducing the degradation of AXL. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.01018-18","DOI":"10.1128\/JVI.01018-18"},{"key":"17_CR31","doi-asserted-by":"publisher","unstructured":"Rana, J., et al.: Role of capsid anchor in the morphogenesis of zika virus. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.01174-18","DOI":"10.1128\/JVI.01174-18"},{"key":"17_CR32","doi-asserted-by":"publisher","unstructured":"Kretschmer, M., et al.: Zikavirus prME envelope Pseudotyped human immunodeficiency virus Type-1 as a novel tool for glioblastoma-directed virotherapy. Cancer. 12 (2020). https:\/\/doi.org\/10.3390\/cancers12041000","DOI":"10.3390\/cancers12041000"},{"key":"17_CR33","doi-asserted-by":"publisher","unstructured":"Ruiz-Jimenez, F., et al.: Challenges on the development of a pseudotyping assay for zika glycoproteins. J. Med. Microbiol. 70 (2021). https:\/\/doi.org\/10.1099\/jmm.0.001413","DOI":"10.1099\/jmm.0.001413"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/jvh.13026","volume":"26","author":"J Huang","year":"2019","unstructured":"Huang, J., Yin, P., Zhang, L.: COPII cargo claudin-12 promotes hepatitis C virus entry. J. Viral Hepat. 26, 308\u2013312 (2019). https:\/\/doi.org\/10.1111\/jvh.13026","journal-title":"J. Viral Hepat."},{"key":"17_CR35","doi-asserted-by":"publisher","unstructured":"Gallard, C., et al.: Heparanase-1 is upregulated by hepatitis C virus and favors its replication. J. Hepatol. (2022). https:\/\/doi.org\/10.1016\/j.jhep.2022.01.008","DOI":"10.1016\/j.jhep.2022.01.008"},{"key":"17_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110859","volume":"39","author":"JM Pfaff-Kilgore","year":"2022","unstructured":"Pfaff-Kilgore, J.M., et al.: Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Rep. 39, 110859 (2022). https:\/\/doi.org\/10.1016\/j.celrep.2022.110859","journal-title":"Cell Rep."},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-4939-8976-8_15","volume":"1911","author":"S Denolly","year":"2019","unstructured":"Denolly, S., Cosset, F.L., Freitas, N.: Membrane fusion assays for studying entry hepatitis C virus into cells. Methods in molecular biology (Clifton, N.J.). 1911, 219\u2013234 (2019). https:\/\/doi.org\/10.1007\/978-1-4939-8976-8_15","journal-title":"Methods in molecular biology (Clifton, N.J.)"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-1-4939-8976-8_30","volume":"1911","author":"JR Bailey","year":"2019","unstructured":"Bailey, J.R., Urbanowicz, R.A., Ball, J.K., Law, M., Foung, S.K.H.: Standardized method for the study of antibody neutralization of HCV Pseudoparticles (HCVpp). Methods in molecular biology (Clifton, N.J.). 1911, 441\u2013450 (2019). https:\/\/doi.org\/10.1007\/978-1-4939-8976-8_30","journal-title":"Methods in molecular biology (Clifton, N.J.)"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fimmu.2019.01145","volume":"10","author":"MG Masavuli","year":"2019","unstructured":"Masavuli, M.G., et al.: A hepatitis C virus DNA vaccine encoding a secreted, oligomerized form of envelope proteins is highly immunogenic and elicits neutralizing antibodies in vaccinated mice. Front. Immunol. 10, 1145 (2019). https:\/\/doi.org\/10.3389\/fimmu.2019.01145","journal-title":"Front. Immunol."},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcmgh.2020.08.009","volume":"11","author":"M Dent","year":"2021","unstructured":"Dent, M., et al.: Safety and efficacy of Avaren-fc Lectibody targeting HCV high-mannose glycans in a human liver chimeric mouse model. Cell. Mol. Gastroenterol. Hepatol. 11, 185\u2013198 (2021). https:\/\/doi.org\/10.1016\/j.jcmgh.2020.08.009","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1074\/jbc.RA120.013015","volume":"295","author":"RJ Center","year":"2020","unstructured":"Center, R.J., et al.: Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine. J. Biol. Chem. 295, 7179\u20137192 (2020). https:\/\/doi.org\/10.1074\/jbc.RA120.013015","journal-title":"J. Biol. Chem."},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jhep.2019.02.013","volume":"71","author":"SJ Merat","year":"2019","unstructured":"Merat, S.J., et al.: Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance. J. Hepatol. 71, 14\u201324 (2019). https:\/\/doi.org\/10.1016\/j.jhep.2019.02.013","journal-title":"J. Hepatol."},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2018.11.003","volume":"70","author":"T Khera","year":"2019","unstructured":"Khera, T., et al.: Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants. J. Hepatol. 70, 593\u2013602 (2019). https:\/\/doi.org\/10.1016\/j.jhep.2018.11.003","journal-title":"J. Hepatol."},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2021.10.005","volume":"162","author":"JH Salas","year":"2022","unstructured":"Salas, J.H., et al.: An antigenically diverse, representative panel of envelope glycoproteins for hepatitis C virus vaccine development. Gastroenterology. 162, 562\u2013574 (2022). https:\/\/doi.org\/10.1053\/j.gastro.2021.10.005","journal-title":"Gastroenterology"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2022.01.010","volume":"55","author":"M Bonsignori","year":"2022","unstructured":"Bonsignori, M., Marcotrigiano, J.: HCV neutralization goes elite. Immunity. 55, 195\u2013197 (2022). https:\/\/doi.org\/10.1016\/j.immuni.2022.01.010","journal-title":"Immunity"},{"key":"17_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256816","volume":"16","author":"A Ahsan","year":"2021","unstructured":"Ahsan, A., et al.: Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus. PLoS One. 16, e0256816 (2021). https:\/\/doi.org\/10.1371\/journal.pone.0256816","journal-title":"PLoS One"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2019.11.011","volume":"72","author":"NA Brasher","year":"2020","unstructured":"Brasher, N.A., et al.: B cell immunodominance in primary hepatitis C virus infection. J. Hepatol. 72, 670\u2013679 (2020). https:\/\/doi.org\/10.1016\/j.jhep.2019.11.011","journal-title":"J. Hepatol."},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1016\/j.vaccine.2020.08.066","volume":"38","author":"AI Mosa","year":"2020","unstructured":"Mosa, A.I., et al.: A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice. Vaccine. 38, 6864\u20136867 (2020). https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.066","journal-title":"Vaccine"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","volume":"156","author":"N Hamdane","year":"2019","unstructured":"Hamdane, N., et al.: HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response. Gastroenterology. 156, 2313\u20132329.e2317 (2019). https:\/\/doi.org\/10.1053\/j.gastro.2019.02.038","journal-title":"Gastroenterology"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2174\/1573406416999200818150053","volume":"17","author":"KX Zhang","year":"2021","unstructured":"Zhang, K.X., et al.: Synthesis and in vitro anti-HCV and antitumor evaluation of Schisandronic acid derivatives. Medicinal chemistry (Shariqah (United Arab Emirates)). 17, 974\u2013982 (2021). https:\/\/doi.org\/10.2174\/1573406416999200818150053","journal-title":"Medicinal chemistry (Shariqah (United Arab Emirates))"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2021.12.011","volume":"76","author":"\u00c9 Beaumont","year":"2022","unstructured":"Beaumont, \u00c9., et al.: IL-26 inhibits hepatitis C virus replication in hepatocytes. J. Hepatol. 76, 822\u2013831 (2022). https:\/\/doi.org\/10.1016\/j.jhep.2021.12.011","journal-title":"J. Hepatol."},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.06.022","volume":"567","author":"X Zheng","year":"2021","unstructured":"Zheng, X., et al.: Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virus. Biochem. Biophys. Res. Commun. 567, 1\u20138 (2021). https:\/\/doi.org\/10.1016\/j.bbrc.2021.06.022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.bmcl.2019.01.008","volume":"29","author":"A Magri","year":"2019","unstructured":"Magri, A., Mokrane, O., Lauder, K., Patel, A.H., Castagnolo, D.: Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV). Bioorg. Med. Chem. Lett. 29, 724\u2013728 (2019). https:\/\/doi.org\/10.1016\/j.bmcl.2019.01.008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"17_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113395","volume":"218","author":"H Zhang","year":"2021","unstructured":"Zhang, H., et al.: Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: synthesis and biological evaluation. Eur. J. Med. Chem. 218, 113395 (2021). https:\/\/doi.org\/10.1016\/j.ejmech.2021.113395","journal-title":"Eur. J. Med. Chem."},{"key":"17_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104734","volume":"177","author":"X Li","year":"2020","unstructured":"Li, X., et al.: Long-chain fatty acyl-coenzyme a suppresses hepatitis C virus infection by targeting virion-bound lipoproteins. Antivir. Res. 177, 104734 (2020). https:\/\/doi.org\/10.1016\/j.antiviral.2020.104734","journal-title":"Antivir. Res."},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phymed.2018.09.025","volume":"53","author":"TC Hung","year":"2019","unstructured":"Hung, T.C., et al.: Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Phytomedicine : international journal of phytotherapy and phytopharmacology. 53, 62\u201369 (2019). https:\/\/doi.org\/10.1016\/j.phymed.2018.09.025","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bmc.2018.12.038","volume":"27","author":"B Li","year":"2019","unstructured":"Li, B., et al.: Harzianoic acids a and B, new natural scaffolds with inhibitory effects against hepatitis C virus. Bioorg. Med. Chem. 27, 560\u2013567 (2019). https:\/\/doi.org\/10.1016\/j.bmc.2018.12.038","journal-title":"Bioorg. Med. Chem."},{"key":"17_CR58","doi-asserted-by":"publisher","unstructured":"Shahid, M., et al.: An engineered Microvirin variant with identical structural domains potently inhibits human immunodeficiency virus and hepatitis C virus cellular entry. Viruses. 12 (2020). https:\/\/doi.org\/10.3390\/v12020199","DOI":"10.3390\/v12020199"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"128788","DOI":"10.1016\/j.cej.2021.128788","volume":"414","author":"Y Tong","year":"2021","unstructured":"Tong, Y., et al.: Photo-catalyzed TiO(2) inactivates pathogenic viruses by attacking viral genome. Chemical engineering journal (Lausanne, Switzerland : 1996). 414, 128788 (2021). https:\/\/doi.org\/10.1016\/j.cej.2021.128788","journal-title":"Chemical engineering journal (Lausanne, Switzerland : 1996)"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S., et al.: AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 31, 126\u2013140 (2021). https:\/\/doi.org\/10.1038\/s41422-020-00460-y","journal-title":"Cell Res."},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2016.03.012","volume":"18","author":"TJ Nowakowski","year":"2016","unstructured":"Nowakowski, T.J., et al.: Expression analysis highlights AXL as a candidate zika virus entry receptor in neural stem cells. Cell Stem Cell. 18, 591\u2013596 (2016). https:\/\/doi.org\/10.1016\/j.stem.2016.03.012","journal-title":"Cell Stem Cell"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1084\/jem.20171093","volume":"214","author":"Z Zhu","year":"2017","unstructured":"Zhu, Z., et al.: Zika virus has oncolytic activity against glioblastoma stem cells. J. Exp. Med. 214, 3145 (2017). https:\/\/doi.org\/10.1084\/jem.20171093","journal-title":"J. Exp. Med."},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1016\/j.vaccine.2009.07.059","volume":"27","author":"B Bellier","year":"2009","unstructured":"Bellier, B., et al.: DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine. 27, 5772\u20135780 (2009). https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.059","journal-title":"Vaccine"},{"key":"17_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177882","volume":"12","author":"S Mercier-Delarue","year":"2017","unstructured":"Mercier-Delarue, S., et al.: Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype. PLoS One. 12, e0177882 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0177882","journal-title":"PLoS One"}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:25:48Z","timestamp":1678879548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_17","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}